Gareth Morgan, MD, FRCP, FRCPath, PhD, began his medical education at the University of Wales before completing fellowships in hematology and pathology at the Royal College of Physicians in London. With a keen interest in hematology, he undertook his doctorate at the University of London, focused on the genetics of leukemia. Dr Morgan practiced at The Royal Marsden NHS Foundation Trust and The Institute of Cancer Research in London, where he was a Professor of Hematology and Director of the Centre for Myeloma Research. In 2014, he moved his clinical and academic roles to the University of Arkansas for Medical Sciences, serving as Director of the Myeloma Institute and Professor of Hematology.
Dr Morgan currently serves as a Director and Professor at New York University Langone Health. Over his career, he has gained recognition as an international expert and distinguished thought leader on multiple myeloma, with over 500 peer reviewed publications and as a regular presenter at major global scientific meetings.
Speaking on the genetics of multiple myeloma
Dr Morgan has been a key influencer in the myeloma field through his renowned work on myeloma genetics and tailored treatments. His extensive research has included identification of key drivers that define ultra-high-risk disease, determining the significance of chromosomal aberrations, contributing to the characterization of the Philadelphia chromosome, and investigating the role of cellular evolution in disease progression. He also works on amyloidosis, Waldenstrom macroglobulinemia, and pre-myeloma conditions to develop strategies to prevent progression. Dr Morgan’s considerable research efforts have named him a major force in translating molecular advances into clinical solutions.